In-Vitro Diagnostics (IVD) Quality Control Market 2020 dynamics (drivers, restraints, opportunities), Plans, Competitive Landscape and Growth by Forecast to 2027 - PowerPoint PPT Presentation

About This Presentation

In-Vitro Diagnostics (IVD) Quality Control Market 2020 dynamics (drivers, restraints, opportunities), Plans, Competitive Landscape and Growth by Forecast to 2027


The market is heavily consolidated owing to a large number of global, regional, and local key contenders having already established a significant footing. – PowerPoint PPT presentation

Number of Views:43


Transcript and Presenter's Notes

Title: In-Vitro Diagnostics (IVD) Quality Control Market 2020 dynamics (drivers, restraints, opportunities), Plans, Competitive Landscape and Growth by Forecast to 2027

In-Vitro Diagnostics (IVD) Quality Control
Analyzed by Business Growth, Development Factors,
Applications, and Future Prospects 2027
Market Summary
According to the current analysis of Reports and
Data, the global In-Vitro Diagnostics (IVD)
Quality Control Market was valued at USD 881.8
Million in 2018 and is expected to reach USD
1229.3 Million by year 2026, at a CAGR of
4.3. IVD quality controls are tests used to
authenticate the consistency of IVD testing
system to confirm precision of test findings and
assess the influence of factors such as
environmental conditions and operators
performance on test results. Key recent
developments in June 2019, Illumina, Inc.
announced the launch of VeriSeq NIPT Solution v2,
a CE-IVD next-generation sequencing (NGS)-based
approach to noninvasive prenatal testing (NIPT),
delivers the most comprehensive view of the fetal
genome compared to other CE-IVD NIPT
products. Factors including increasing
prevalence of chronic diseases, launch of new
clinical laboratories, stringent mandates, as
well as rising need of early diagnostics by
patients drive the growth of In-Vitro Diagnostics
(IVD) Quality Control market. Increasing
incidence of public-private laboratories which
are undergoing laboratory accreditation procedure
even boosts up the growth of this particular
market. For instance In August 2018, Abbott
Laboratories introduced Alinity, its
state-of-the-art, harmonized family of systems
for clinical diagnostics, to the US market
indicating high demand for the systems advanced
capabilities and potential to provide savings and
increased efficiencies for labs, clinicians, and
Frequently progressing technology-oriented
changes in the diagnostics field and rising need
to guarantee patient safety require the
application of quality assurance programs in
various medical disciplines. The growth in the
IVD quality controls market is mainly propelled
by the increasing number of accredited
laboratories and growing mandates on the use of
quality controls from regulatory and
accreditation bodies. For instance in April
2019, The University of Antwerp, bioMérieux and
Wellcome Trust launched VALUE-Dx, the first
Innovative Medicines Initiative (IMI) project
initiated by six in vitro diagnostic companies
who join forces with 20 non-industry partners to
combat antimicrobial resistance (AMR) and improve
patient outcomes. The COVID-19 impact As the
COVID-19 crisis grows, manufacturers are quickly
changing their practice and purchasing priorities
to meet the required demand of a pandemic, which
has cut the need for In-Vitro Diagnostics (IVD)
Quality Control for construction in the market.
Over a couple of months, there will be a series
of both positive and negative shocks, as
manufacturers and their suppliers respond to
providers changing needs. With an unfortunate
global situation, the export-dependent economies
of many regions look vulnerable.
Companies considered and profiled in this market
studyAgilent Technologies, Abbott Diagnostics,
Becton, Dickinson and Company, BioMerieux, Inc.,
Bio-Techne, Bio-Rad Laboratories, Inc., DiaSorin,
Fortress Diagnostics, Future Diagnostics
Solutions, Helena Laboratories, Hologic, Inc.,
Illumina, Laboratory Corporation, Quidel
Corporation, Roche Diagnostics, Randox
Laboratories Ltd., Seracare Life Sciences, Inc.,
Sun Diagnostics, LLC., Sero AS, Sysmex
Corporation, Surmodics, Inc., Siemens Healthcare
GmbH, Technopath Clinical Diagnostics, and Thermo
Fisher Scientific, Inc. Get Free Report Sample _at_
/1508 Application Outlook Based on the
application, the pit and fissure sealant
segmented is more likely to drive the industry
forward. It is speculated to be the largest
segment of the dental adhesive industry owing to
the budget-friendly dental filling, as well as
their increased efficacy in filling up the
cavities. The younger generation is more prone to
dental cavities, and so they form the major
consumer base of this application. End-User
Outlook Based on the end-use, dental clinics
and hospitals are predicted to hold the largest
share in the end-user segment credited to the
rising patient population, adoption of innovative
and advanced dental technology, and an increase
in the tally of hospitals and clinics. On the
other hand, the rising prevalence of cosmetic
dentistry and restorative dentistry are fueling
the expansion of the dental adhesives market.
  • For the purpose of this report, Reports and Data
    have segmented into the global In-Vitro
    Diagnostics (IVD) Quality Control Market for
    Construction on the basis of type, end-use,
    application, and region
  • Manufacturer Type (Revenue, USD Million
  • Instrument Manufacturer Controls
  • Independent Manufacturer Controls
  • Third-party Controls
  • Instrument Specific Manufacturer Controls
  • Application (Revenue, USD Million 20162026)
  • Clinical Chemistry
  • Immunochemistry
  • Haematology
  • Molecular Diagnostics
  • Coagulation/Haemostasis
  • Microbiology
  • Others
  • Regional Outlook (Volume, Kilo Tons 2017-2027)
    (Revenue, USD Billion 2017-2027)
  • North America
  • U.S
  • Europe
  • U.K
  • France
  • Asia Pacific
  • China
  • India
  • Japan
  • MEA
  • Latin America
  • Brazil
  • Browse Complete Report In-Vitro Diagnostics
    (IVD) Quality Control Market for Construction By
    Type, By End-Use, By Application, By Region,
    Forecasts To 2017-2027 _at_ https//www.reportsandda
  • Further key findings from the report suggest
  • The American Clinical Laboratory Association
    (ACLA) states that more than 7.5 billion lab
    tests are performed in U.S. annually and 80 of
    clinical decisions are taken after lab testing
  • In December 2018, BioMérieux announced its
    culture bottles BACT/ALERT BPA and BPN have
    received 510(k) clearance from the U.S. Food and
    Drug Administration (FDA) for quality control
    testing of leukocyte-reduced apheresis platelet
    (LRAP) units with the BACT/ALERT VIRTUO fully
    automated blood culture system
  • In-Vitro Diagnostics (IVD) Quality Control Market
    is fastest growing at a CAGR of 3 in Asia
    Pacific owing to rising incidence of IVD tests in
    developing countries such as India and China due
    to upsurge in number of clinical laboratories,
    global awareness among patients
  • Data Management Solutions segment is accounted to
    be the second-leading segment which is valued at
    USD 155.6 million because it gives access to LIS
    and easy for managing test results of patients
    and even popular due to dependable laboratory
  • Europe is the second largest region with a CAGR
    of 4.0 due to acceptance of point of care
    diagnostics across Europe especially in regions
    in UK, Denmark, Poland and Slovenia
  • Home Care segment is the fastest growing at a
    CAGR of 5.3 because they are providing PoC
    instruments which give ease of convenience for
    the patient who requires everyday testing and
    further reduces hospital visits
About Us
Reports and Data is a market research and
consulting company that provides syndicated
research reports, customized research reports,
and consulting services. Our solutions purely
focus on your purpose to locate, target and
analyze consumer behavior shifts across
demographics, across industries and help clients
make a smarter business decision. We offer
market intelligence studies ensuring relevant and
fact-based research across a multiple industries
including Healthcare, Technology, Chemicals,
Power, and Energy. We consistently update our
research offerings to ensure our clients are
aware about the latest trends existent in the
market. Reports and Data has a strong base of
experienced analysts from varied areas of
Contact US
John Watson Head of Business Development Reports
And Data Web Direct
Line 1-212-710-1370 E-mail sales_at_reportsanddata
Write a Comment
User Comments (0)